Table 1: Features of trials of routine serial prenatal ultrasound screening1


Variable Eik-Nes et al  1984<7> Bakketeig et al  1984<8> Neilson et al 1984<9> Ewigman et al  1993<10>

Type of population General General Low-risk Low-risk
Sample size
Experimental Group  819 510 433 7,812
Control Group 809 499 444 7,718
Interventions
Experimental Group Measurement of BPD at 16 weeks and of BPD and AD at 32 weeks.  Measurement of BPD at 19 weeks  and of BPD and AD at 32 weeks.  Measurement of CRL and TA at 24 and 35 weeks.  Measurement of placental location, BPD, AC, FL and detailed 
anatomical survey at 18-20 weeks and at 31-33 weeks. 
Control Group Routine care Routine care Done, but results not reported to doctor Routine care

 1 BPD = biparietal diameter, AD = Abdominal diameter, CRL = crown-rump length, TA = trunk area, AC = abdominal circumference, FL = femur length